2024 annual financial data
Context Therapeutics 2024 Operating margin
Context Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -29,923,900 USD and net income was -26,725,104 USD.
Operating cash flow was -14,556,000 USD.
Get free Context Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -29,923,900 USD
- Net income
- -26,725,104 USD
- Operating cash flow
- -14,556,000 USD